News and Announcements
Kingdom Developments releases Progress Report
- Published December 16, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Kingdom Developments releases Progress Report, a quarterly review for July – September 2019.
The future looks promising for our developments in Sydney, Wollongong and Queensland. The following report provides an insight into current trends and the investment return that can be expected over the next 1 -5 years in our high-growth locations.
To get a copy of the report and gain access to industry news and future projects please sign up here
About Kingdom Developments
Kingdom Developments Australia (KDA) came from our passion for investment vehicles that offer our investors (including us) an exceptional risk vs reward ratio. Our SPV structures allow for investors to join together to co-own and access larger scale property developments than they could individually and in doing so allow for greater efficiencies in economies of scale and stronger returns.
Our vehicle is especially appreciated by investors that have limited time, yet want the lucrative returns of medium to large property developments.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
